Head and neck INI1-deficient carcinoma without primary: a case report.

Antoine Dubray-VautrinWahib GhanemLaurence BozecJulie GoninOlivier Choussy

Published in: Journal of medical case reports (2023)

Research of INI1 deletion should be performed for undifferentiated carcinoma of young patients because of possibilities of molecular therapies such as autophagy inhibitors or proteasome inhibitors could be used in clinical trials.

Keyphrases

clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cell death
oxidative stress
endoplasmic reticulum stress
randomized controlled trial
single molecule